我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2005
已完成
100.0%
暂无批准数据
- LinusBio and Autism Speaks have partnered to promote ClearStrand-ASD, a first-in-class biochemical test that identifies autism biomarkers in hair strands of infants and toddlers aged 1-36 months. - The collaboration will integrate the diagnostic tool with Autism Speaks' Autism Response Team and upcoming Empower Summit events, while providing educational resources and reduced-cost testing for families in need. - Early diagnosis is critical for autism intervention, with ClearStrand-ASD offering healthcare providers a new screening option for children at elevated risk, including those born preterm or with siblings on the autism spectrum.